4//SEC Filing
Astor Andrew 4
Accession 0000914190-20-000105
CIK 0001196298other
Filed
Mar 4, 7:00 PM ET
Accepted
Mar 5, 5:10 PM ET
Size
14.1 KB
Accession
0000914190-20-000105
Insider Transaction Report
Form 4
NEPHROS INCNEPH
Astor Andrew
Chief Financial Officer
Transactions
- Purchase
Common Stock
2020-03-05$8.46/sh+700$5,920→ 69,008 total
Holdings
- 14,815
Warrants (right to buy)
Exercise: $2.70From: 2017-03-17Exp: 2022-03-17→ Common Stock (14,815 underlying) - 64,399
Stock Option (right to buy)
Exercise: $4.14Exp: 2027-02-13→ Common Stock (64,399 underlying) - 46,525
Stock Option (right to buy)
Exercise: $2.64Exp: 2027-05-01→ Common Stock (46,525 underlying) - 5,556
Stock Option (right to buy)
Exercise: $4.50Exp: 2027-12-20→ Common Stock (5,556 underlying) - 22,223
Stock Option (right to buy)
Exercise: $5.85Exp: 2028-12-19→ Common Stock (22,223 underlying) - 20,000
Stock Option (right to buy)
Exercise: $8.30Exp: 2029-12-16→ Common Stock (20,000 underlying)
Footnotes (5)
- [F1]On 2/13/17, the Reporting Person was granted an option to purchase 64,399 shares of common stock of the Company. Options to purchase 8,049 shares vested on 2/13/18; options to purchase 24,150 shares vest quarterly in 12 equal amounts commencing on 5/13/18; and options to purchase 32,200 shares vested upon achievement of previously disclosed performance measures.
- [F2]On 5/1/17, the Reporting Person was granted an option to purchase 46,525 shares of common stock of the Company. Options to purchase 5,815 shares vested on 5/1/18; options to purchase 17,447 shares vest quarterly in 12 equal amounts commencing on 7/1/18; and options to purchase 23,263 shares vested upon achievement of previously disclosed performance measures.
- [F3]On 12/20/17, the Reporting Person was granted an option to purchase 5,556 shares of common stock of the Company. Options to purchase 1,389 shares vested on 12/20/18 and options to purchase 4,167 shares vest quarterly in 12 equal amounts commencing on 3/20/19.
- [F4]On 12/19/18, the Reporting Person was granted an option to purchase 22,223 shares of common stock of the Company. Options to purchase 5,555 shares vested on 12/19/19 and options to purchase 16,668 shares vest quarterly in 12 equal amounts commencing on 3/19/20.
- [F5]On 12/16/19, the Reporting Person was granted an option to purchase 20,000 shares of common stock of the Company. Options to purchase 5,000 shares vest on 12/16/20 and options to purchase 15,000 shares vest quarterly in 12 equal amounts commencing on 3/16/21.
Documents
Issuer
NEPHROS INC
CIK 0001196298
Entity typeother
Related Parties
1- filerCIK 0001698052
Filing Metadata
- Form type
- 4
- Filed
- Mar 4, 7:00 PM ET
- Accepted
- Mar 5, 5:10 PM ET
- Size
- 14.1 KB